2024-04-012025-03-312025-03-31false12467712GROVELEY HEALTH LIMITED2025-10-21falseiso4217:GBPxbrli:pure124677122024-03-31124677122025-03-31124677122024-04-012025-03-31124677122023-03-31124677122024-03-31124677122023-04-012024-03-3112467712bus:SmallEntities2024-04-012025-03-3112467712bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3112467712bus:FullAccounts2024-04-012025-03-3112467712bus:PrivateLimitedCompanyLtd2024-04-012025-03-3112467712core:WithinOneYear2025-03-3112467712core:AfterOneYear2025-03-3112467712core:WithinOneYear2024-03-3112467712core:AfterOneYear2024-03-3112467712core:ShareCapital2025-03-3112467712core:SharePremium2025-03-3112467712core:RevaluationReserve2025-03-3112467712core:OtherReservesSubtotal2025-03-3112467712core:RetainedEarningsAccumulatedLosses2025-03-3112467712core:ShareCapital2024-03-3112467712core:SharePremium2024-03-3112467712core:RevaluationReserve2024-03-3112467712core:OtherReservesSubtotal2024-03-3112467712core:RetainedEarningsAccumulatedLosses2024-03-3112467712core:LandBuildings2025-03-3112467712core:PlantMachinery2025-03-3112467712core:Vehicles2025-03-3112467712core:FurnitureFittings2025-03-3112467712core:OfficeEquipment2025-03-3112467712core:NetGoodwill2025-03-3112467712core:IntangibleAssetsOtherThanGoodwill2025-03-3112467712core:ListedExchangeTraded2025-03-3112467712core:UnlistedNon-exchangeTraded2025-03-3112467712core:LandBuildings2024-03-3112467712core:PlantMachinery2024-03-3112467712core:Vehicles2024-03-3112467712core:FurnitureFittings2024-03-3112467712core:OfficeEquipment2024-03-3112467712core:NetGoodwill2024-03-3112467712core:IntangibleAssetsOtherThanGoodwill2024-03-3112467712core:ListedExchangeTraded2024-03-3112467712core:UnlistedNon-exchangeTraded2024-03-3112467712core:LandBuildings2024-04-012025-03-3112467712core:PlantMachinery2024-04-012025-03-3112467712core:Vehicles2024-04-012025-03-3112467712core:FurnitureFittings2024-04-012025-03-3112467712core:OfficeEquipment2024-04-012025-03-3112467712core:NetGoodwill2024-04-012025-03-3112467712core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112467712core:ListedExchangeTraded2024-04-012025-03-3112467712core:UnlistedNon-exchangeTraded2024-04-012025-03-3112467712core:MoreThanFiveYears2024-04-012025-03-3112467712core:Non-currentFinancialInstruments2025-03-3112467712core:Non-currentFinancialInstruments2024-03-3112467712dpl:CostSales2024-04-012025-03-3112467712dpl:DistributionCosts2024-04-012025-03-3112467712core:LandBuildings2024-04-012025-03-3112467712core:PlantMachinery2024-04-012025-03-3112467712core:Vehicles2024-04-012025-03-3112467712core:FurnitureFittings2024-04-012025-03-3112467712core:OfficeEquipment2024-04-012025-03-3112467712dpl:AdministrativeExpenses2024-04-012025-03-3112467712core:NetGoodwill2024-04-012025-03-3112467712core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112467712dpl:GroupUndertakings2024-04-012025-03-3112467712dpl:ParticipatingInterests2024-04-012025-03-3112467712dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3112467712core:ListedExchangeTraded2024-04-012025-03-3112467712dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3112467712core:UnlistedNon-exchangeTraded2024-04-012025-03-3112467712dpl:CostSales2023-04-012024-03-3112467712dpl:DistributionCosts2023-04-012024-03-3112467712core:LandBuildings2023-04-012024-03-3112467712core:PlantMachinery2023-04-012024-03-3112467712core:Vehicles2023-04-012024-03-3112467712core:FurnitureFittings2023-04-012024-03-3112467712core:OfficeEquipment2023-04-012024-03-3112467712dpl:AdministrativeExpenses2023-04-012024-03-3112467712core:NetGoodwill2023-04-012024-03-3112467712core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112467712dpl:GroupUndertakings2023-04-012024-03-3112467712dpl:ParticipatingInterests2023-04-012024-03-3112467712dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112467712core:ListedExchangeTraded2023-04-012024-03-3112467712dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112467712core:UnlistedNon-exchangeTraded2023-04-012024-03-3112467712core:NetGoodwill2025-03-3112467712core:IntangibleAssetsOtherThanGoodwill2025-03-3112467712core:LandBuildings2025-03-3112467712core:PlantMachinery2025-03-3112467712core:Vehicles2025-03-3112467712core:FurnitureFittings2025-03-3112467712core:OfficeEquipment2025-03-3112467712core:AfterOneYear2025-03-3112467712core:WithinOneYear2025-03-3112467712core:ListedExchangeTraded2025-03-3112467712core:UnlistedNon-exchangeTraded2025-03-3112467712core:ShareCapital2025-03-3112467712core:SharePremium2025-03-3112467712core:RevaluationReserve2025-03-3112467712core:OtherReservesSubtotal2025-03-3112467712core:RetainedEarningsAccumulatedLosses2025-03-3112467712core:NetGoodwill2024-03-3112467712core:IntangibleAssetsOtherThanGoodwill2024-03-3112467712core:LandBuildings2024-03-3112467712core:PlantMachinery2024-03-3112467712core:Vehicles2024-03-3112467712core:FurnitureFittings2024-03-3112467712core:OfficeEquipment2024-03-3112467712core:AfterOneYear2024-03-3112467712core:WithinOneYear2024-03-3112467712core:ListedExchangeTraded2024-03-3112467712core:UnlistedNon-exchangeTraded2024-03-3112467712core:ShareCapital2024-03-3112467712core:SharePremium2024-03-3112467712core:RevaluationReserve2024-03-3112467712core:OtherReservesSubtotal2024-03-3112467712core:RetainedEarningsAccumulatedLosses2024-03-3112467712core:NetGoodwill2023-03-3112467712core:IntangibleAssetsOtherThanGoodwill2023-03-3112467712core:LandBuildings2023-03-3112467712core:PlantMachinery2023-03-3112467712core:Vehicles2023-03-3112467712core:FurnitureFittings2023-03-3112467712core:OfficeEquipment2023-03-3112467712core:AfterOneYear2023-03-3112467712core:WithinOneYear2023-03-3112467712core:ListedExchangeTraded2023-03-3112467712core:UnlistedNon-exchangeTraded2023-03-3112467712core:ShareCapital2023-03-3112467712core:SharePremium2023-03-3112467712core:RevaluationReserve2023-03-3112467712core:OtherReservesSubtotal2023-03-3112467712core:RetainedEarningsAccumulatedLosses2023-03-3112467712core:AfterOneYear2024-04-012025-03-3112467712core:WithinOneYear2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112467712core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3112467712core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3112467712core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3112467712core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3112467712core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3112467712core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3112467712core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3112467712core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3112467712core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3112467712core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112467712core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112467712core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112467712core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112467712core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112467712core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112467712core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112467712core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112467712core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112467712bus:Director12024-04-012025-03-31

GROVELEY HEALTH LIMITED

Registered Number
12467712
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

GROVELEY HEALTH LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

ISMAIL, Salim, Dr

Registered Address

Fulford Lodge
1 Heslington Lane
York
YO10 4HW

Registered Number

12467712 (England and Wales)
GROVELEY HEALTH LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors16,733-
16,733-
Creditors amounts falling due within one year3(4,421)-
Net current assets (liabilities)12,312-
Total assets less current liabilities12,312-
Net assets12,312-
Capital and reserves
Called up share capital2-
Profit and loss account12,310-
Shareholders' funds12,312-
The financial statements were approved and authorised for issue by the Director on 21 October 2025, and are signed on its behalf by:
ISMAIL, Salim, Dr
Director
Registered Company No. 12467712
GROVELEY HEALTH LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year20
3.Creditors: amounts due within one year

2025

2024

££
Taxation and social security2,887-
Accrued liabilities and deferred income1,534-
Total4,421-
4.Related party transactions
During the year the company loaned the director £16,733. This loan is repayable upon demand. Interest was charged on the loan at the monthly UK market rate.